
|Articles|October 1, 2007
- Volume 0 0
Seven Deadly Sins AND HOW TO AVOID THEM: Interviews
Advertisement
- ARRIVING LATE?Set 2 alarm clocks, and allow more than enough travel time.
- DRESSING INFORMALLY?Have a dry-cleaned, conservative business suit ready to go.
- POOR EYE CONTACT?Concentrate on maintaining eye contact throughout the interview. Eye contact is not the same asstaring.
- ASKING ONLY SELF-SERVING QUESTIONS?Prepare questions that show your interest in the position or company.
- DEMONSTRATING IGNORANCE ABOUT THE HIRING COMPANY?Do some background research on the companybefore the interview.
- USING EVERYDAY LANGUAGE AND SPEECH PATTERNS?Practice interviewing and using professional terminologywhere appropriate. Avoid ?like,? ?ya know,? ?really,? and ?OK?? when they are simply fillers.
- FAILING TO ADDRESS THE QUESTION ASKED?Be careful to listen to the question and understand it before answering.
Articles in this issue
over 18 years ago
PRUITT-SCHUTTE COMPETITION STRIVES FOR EXCELLENCEover 18 years ago
DOCTOR TOM'S TOP TEN TIPS: PASSING THE PHARMACY BOARDSover 18 years ago
PHARMACY GROUPS JOIN TOGETHER TO IMPROVE SERVICEover 18 years ago
STUDENT POLITICAL INVOLVEMENT DOES IMPACT PHARMACYover 18 years ago
Seven Deadly Sins AND HOW TO AVOID THEM: R?sum?over 18 years ago
OWNING YOUR OWN PHARMACY: A PLAN AND PARTNERSHIP COME TOGETHERover 18 years ago
TECHNOLOGY EXPANDS PHARMACY REACH IN UNDERSERVED RURAL AREASover 18 years ago
PARTNERSHIP PROGRAMS?A WIN-WIN FOR COMMUNITY PHARMACISTSover 18 years ago
GOOD NEIGHBOR PHARMACY REWARDS EXCELLENCEover 18 years ago
WELCOME TO INDEPENDENT PHARMACYAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
5





































































































































